Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 4671 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

EDITORIAL

Sulfonylureas: Assets in the past, present and future

Kalra Sanjay, Madhu S V, Bajaj Sarita

Year : 2015| Volume: 19| Issue : 3 | Page no: 314-316

   This article has been cited by
 
1 CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with T2D trial
Baishali Nath,VirajRamesh Suvarna
Perspectives in Clinical Research. 2020; 11(1): 44
[Pubmed]  [Google Scholar] [DOI]
2 Modern Sulfonylureas Strike Back Exploring the Freedom of Flexibility
Sanjay Kalra,Deepak Khandelwal
European Endocrinology. 2018; 14(2): 20
[Pubmed]  [Google Scholar] [DOI]
3 Progressing From Metformin to Sulfonylureas or Meglitinides
Joan S. Grant,Lucinda J. Graven
Workplace Health & Safety. 2016; 64(9): 433
[Pubmed]  [Google Scholar] [DOI]

 

Read this article